Risk Factors for Prostate Cancer Detection After a Negative Biopsy: A Novel Multivariable Longitudinal Approach

被引:54
作者
Gann, Peter H. [1 ]
Fought, Angela
Deaton, Ryan
Catalona, William J.
Vonesh, Edward
机构
[1] Univ Illinois, Dept Pathol, Coll Med, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
INTRAEPITHELIAL NEOPLASIA; NEEDLE-BIOPSY; PREDICTING CANCER; 4.0; NG/ML; ANTIGEN; MEN; DIAGNOSIS; SPECIFICITY; POPULATION; SUSPICION;
D O I
10.1200/JCO.2008.20.3422
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose To introduce a novel approach for the time-dependent quantification of risk factors for prostate cancer (PCa) detection after an initial negative biopsy. Patients and Methods Data for 1,871 men with initial negative biopsies and at least one follow-up biopsy were available. Piecewise exponential regression models were developed to quantify hazard ratios (HRs) and define cumulative incidence curves for PCa detection for subgroups with specific patterns of risk factors over time. Factors evaluated included age, race, serum prostate-specific antigen (PSA) concentration, PSA slope, digital rectal examination, dysplastic glands or prostatitis on biopsy, ultrasound gland volume, urinary symptoms, and number of negative biopsies. Results Four hundred sixty-five men had PCa detected, after a mean follow-up time of 2.8 years. All of the factors were independent predictors of PCa detection except for PSA slope, as a result of its correlation with time-dependent PSA level, and race. PSA (HR = 3.90 for > 10 v 2.5 to 3.9 ng/mL), high-grade prostatic intraepithelial neoplasia/atypical glands (HR = 2.97), gland volume (HR = 0.39 for > 50 v < 25 mL), and number of repeat biopsies (HR = 0.36 for two v zero repeat biopsies) were the strongest predictors. Men with high-risk versus low-risk event histories had a 20-fold difference in PCa detection over 5 years. Conclusion Piecewise exponential models provide an approach to longitudinal analysis of PCa risk that allows clinicians to see the interplay of risk factors as they unfold over time for individual patients. With these models, it is possible to identify distinct subpopulations with dramatically different needs for monitoring and repeat biopsy. J Clin Oncol 28: 1714-1720. (C) 2010 by American Society of Clinical Oncology
引用
收藏
页码:1714 / 1720
页数:7
相关论文
共 35 条
  • [1] Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): Association with diagnosis of prostate cancer
    Ananthanarayanan, V
    Deaton, RJ
    Yang, XMJ
    Pins, MR
    Gann, PH
    [J]. PROSTATE, 2005, 63 (04) : 341 - 346
  • [2] [Anonymous], 2010, Survival Analysis Using SAS: A Practical Guide
  • [3] Bostwick DG, 2006, ARCH PATHOL LAB MED, V130, P952
  • [4] Race is not a predictor of prostate cancer detection on repeat prostate biopsy
    Carver, BS
    Bozeman, CB
    Simoneaux, WJ
    Venable, DD
    Kattant, MW
    Eastham, JA
    [J]. JOURNAL OF UROLOGY, 2004, 172 (05) : 1853 - 1855
  • [5] DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING
    CATALONA, WJ
    SMITH, DS
    RATLIFF, TL
    BASLER, JW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08): : 948 - 954
  • [6] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements
    Catalona, WJ
    Smith, DS
    Ornstein, DK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1452 - 1455
  • [7] CATALONA WJ, 1995, JAMA-J AM MED ASSOC, V274, P1214
  • [8] Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies
    Catalona, WJ
    Beiser, JA
    Smith, DS
    [J]. JOURNAL OF UROLOGY, 1997, 158 (06) : 2162 - 2167
  • [9] Is chronic inflammatory change in the prostate the major cause of rising serum prostate-specific antigen in patients with clinical suspicion of prostate cancer?
    Chang, SG
    Kim, CS
    Jeon, SH
    Kim, YW
    Choi, BY
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (02) : 122 - 126
  • [10] Development and external validation of an extended repeat biopsy nomogram
    Chun, Felix K. -H.
    Briganti, Alberto
    Graefen, Markus
    Porter, Christopher
    Montorsi, Francesco
    Haese, Alexander
    Scattoni, Vincenzo
    Borden, Lester
    Steuber, Thomas
    Salonia, Andrea
    Schlomm, Thorsten
    Latchemsetty, Kalyan
    Walz, Jochen
    Kim, Jason
    Eichelberg, Christian
    Currlin, Eike
    Ahyai, Sascha A.
    Erbersdobler, Andreas
    Valiquette, Luc
    Heinzer, Hans
    Rigatti, Patrizio
    Huland, Hartwig
    Karakiewicz, Pierre I.
    [J]. JOURNAL OF UROLOGY, 2007, 177 (02) : 510 - 515